Canada markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
26.22+0.05 (+0.19%)
At close: 04:00PM EDT
26.38 +0.16 (+0.61%)
After hours: 07:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.53B
Enterprise Value 1.85B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)45.21
Price/Book (mrq)2.44
Enterprise Value/Revenue 35.15
Enterprise Value/EBITDA -5.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.85
52-Week Change 3-40.93%
S&P500 52-Week Change 326.49%
52 Week High 347.48
52 Week Low 319.37
50-Day Moving Average 324.93
200-Day Moving Average 329.22

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 31.43M
Shares Outstanding 596.48M
Implied Shares Outstanding 696.48M
Float 895.33M
% Held by Insiders 11.20%
% Held by Institutions 193.40%
Shares Short (Apr 30, 2024) 415.44M
Short Ratio (Apr 30, 2024) 412.75
Short % of Float (Apr 30, 2024) 418.38%
Short % of Shares Outstanding (Apr 30, 2024) 416.01%
Shares Short (prior month Mar 28, 2024) 414.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-394.00%

Management Effectiveness

Return on Assets (ttm)-24.15%
Return on Equity (ttm)-43.60%

Income Statement

Revenue (ttm)52.6M
Revenue Per Share (ttm)0.58
Quarterly Revenue Growth (yoy)129.50%
Gross Profit (ttm)N/A
EBITDA -507.9M
Net Income Avi to Common (ttm)-485.5M
Diluted EPS (ttm)-5.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)791.29M
Total Cash Per Share (mrq)8.2
Total Debt (mrq)110.86M
Total Debt/Equity (mrq)10.70%
Current Ratio (mrq)9.03
Book Value Per Share (mrq)10.76

Cash Flow Statement

Operating Cash Flow (ttm)-405.42M
Levered Free Cash Flow (ttm)-256.11M